NLRP3 and chronic prostatitis: Hence, P2X7R was identified as a new upstream regulator of NLRP3 in chronic prostatitis, and P2X7R-mediated NLRP3 inflammasome activation could induce Th17 cell differentiation and promote chronic prostatitis development.